Xylyx Bio joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Stella Lee

Xylyx Bio joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Xylyx Bio to focus on accelerating the standardization and commercialization of tissue-specific extracellular matrix biomaterials for regenerative medicine and tissue engineering

Cell culture with all the comforts of home
Medicine

Cell culture with all the comforts of home

By overlooking physiologic components of the extracellular environment, researchers risk obtaining misleading or irreproducible results in the critical early stages of drug discovery and development.

Stella Lee

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Medicine

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Fibrosis-specific substrates provide a disease-relevant in-vitro testing platform to inform decision-making in early-stage drug discovery

Stella Lee